Richard Burr: “I do have some concerns about whether VA is living up to President Obama's vision of, 'an unprecedented level of…”

I question whether the agreements both passed and proposed reflect a good deal for patients they are designed to serve.

The response was clear, FDA should be held accountable to its commitments.

I hope to receive that response soon.

Without Orrin, we wouldn't have a generic drug industry.